Ifechi Anyadioha, MD
Interventional Pain Medicine · Mankato, MNNPI 1386873404
Payments from drug & device makers
What this record shows
12 manufacturers reported payments, led by Medtronic at 37.0% of the total. Reporting peaked in 2019 at $2,275 and has fallen 56.1% since, to $999 in 2025.
Across 86 payments — averaging $49.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Si-bone, Inc.$922
- Stryker$640
- Nevro Corp.$516
- Abbott$417
- Biotronik NRO, Inc.$56
- plus $134 from 6 others
What the payments were for
- Travel & lodging$2,33055%
- Food & beverage$1,93245%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 27 | $1,578 |
| Si-bone, Inc. | 6 | $922 |
| Stryker | 2 | $640 |
| Nevro Corp. | 28 | $516 |
| Abbott | 12 | $417 |
| Biotronik NRO, Inc. | 3 | $56 |
| Boston Scientific | 3 | $55 |
| Electronic Waveform Lab, Inc. | 1 | $18 |
| Vertos Medical, Inc. | 1 | $17 |
| Curonix LLC | 1 | $17 |
| Saluda Medical Americas, Inc. | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,262 in reported general payments places this provider in the 65th percentile of 26 interventional pain medicine providers in Minnesota.
See all interventional pain medicine providers in Minnesota →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 102 | $1,587 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 52 | $959 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 55 | $947 |
| Pregabalin | 63 | $927 |
| Methocarbamol | 49 | $845 |
| Oxycodone Hcl | 54 | $701 |
| Tizanidine Hcl | 41 | $479 |
| Cephalexin | 50 | $453 |
| Tramadol Hcl | 55 | $434 |
| Cyclobenzaprine Hcl | 44 | $386 |
| Meloxicam | 13 | $234 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 17 | $177 |
| Baclofen | 13 | $63 |
| Nortriptyline Hcl | 13 | $51 |
| Diazepam | 13 | $27 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Mankato
- Robert LongMankato$892
- Gabriel Pagani-EstevezRochester$179K
- Nima AdimiChaska$114K
- Ryan BirklandRochester$15K
- James ParmeleMaple Grove$13K
- Jason WolffMaple Grove$9K
- Gregory CrewdsonMaplewood$8K
- Jasvinder SinghMaplewood$6K
- Gabriel SmithRochester$5K
- Nicholas CanzanelloRochester$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.